Patent | Date |
---|
Oral Composition of Anti-TNF-Alpha Antibodies App 20190270801 - GAUCHER; Christine ;   et al. | 2019-09-05 |
Pharmaceutical compositions comprising an antibody which binds the human anti-Mullerian hormone receptor type II Grant 10,179,816 - Gaucher , et al. Ja | 2019-01-15 |
Use of ADCC-optimized antibodies for treating low-responder patients Grant 9,879,089 - Bourel , et al. January 30, 2 | 2018-01-30 |
Antibody method for treatment of a disease in which the target cells are cells which express CD20 Grant 9,873,745 - De Romeuf , et al. January 23, 2 | 2018-01-23 |
Novel Pharmaceutical Compositions Comprising An Antibody Which Binds The Human Anti-mullerian Hormone Receptor Type Ii App 20170101478 - GAUCHER; Christine ;   et al. | 2017-04-13 |
Pharmaceutical compositions comprising an antibody which binds the human anti-mullerian hormone receptor type II Grant 9,511,138 - Gaucher , et al. December 6, 2 | 2016-12-06 |
Cytotoxic Antibody Directed Against Type B Lymphoid Hematopoietic Proliferations App 20160060350 - DE ROMEUF; Christophe ;   et al. | 2016-03-03 |
Monoclonal antibody directed against CD20 antigen Grant 9,234,045 - De Romeuf , et al. January 12, 2 | 2016-01-12 |
Use Of Adcc-optimized Antibodies For Treating Weak Patients App 20150307624 - Bourel; Dominique ;   et al. | 2015-10-29 |
Use of ADCC-optimized antibodies for treating weak patients Grant 9,109,020 - Bourel , et al. August 18, 2 | 2015-08-18 |
Novel Pharmaceutical Compositions Comprising An Antibody Which Binds The Human Anti-mullerian Hormone Receptor Type Ii App 20150004156 - Gaucher; Christine ;   et al. | 2015-01-01 |
Use Of Adcc-optimized Antibodies For Treating Weak Patients App 20140017243 - Bourel; Dominique ;   et al. | 2014-01-16 |
Use of ADCC-optimized antibodies for treating weak patients Grant 8,501,171 - Bourel , et al. August 6, 2 | 2013-08-06 |
Anti-rhesus D monoclonal antibody Grant 8,404,241 - Gaucher , et al. March 26, 2 | 2013-03-26 |
Anti-rhesus D Monoclonal Antibody App 20110311556 - Gaucher; Christine ;   et al. | 2011-12-22 |
Cytotoxic Antibodies Directed Against Antibodies Inhibiting Factor Viii App 20110274684 - BEHRENS; Christian ;   et al. | 2011-11-10 |
Cytotoxic antibodies directed against antibodies inhibiting factor VIII Grant 8,038,993 - Behrens , et al. October 18, 2 | 2011-10-18 |
Cytokine production-inducing antibody App 20100323368 - de Romeuf; Christophe ;   et al. | 2010-12-23 |
Use of ADCC-Optimized antibodies for treating weak patients App 20100303826 - Bourel; Dominique ;   et al. | 2010-12-02 |
Use of ADCC-optimized antibodies for treating low-responder patients Grant 7,713,524 - Bourel , et al. May 11, 2 | 2010-05-11 |
Method of measuring activation of effector cells Grant 7,595,165 - Romeuf , et al. September 29, 2 | 2009-09-29 |
Antibody raised against the ldl receptor App 20090175789 - Behrens; Christian ;   et al. | 2009-07-09 |
Cytotoxic Antibodies Directed Against Antibodies Inhibiting Factor VIII App 20090130094 - Behrens; Christian ;   et al. | 2009-05-21 |
Treatment Of Pathologies Which Escape The Immune Response, Using Optimized Antibodies App 20090081216 - de ROMEUF; Christophe ;   et al. | 2009-03-26 |
Cytotoxic Antibody Directed Against Type B Lymphoid Hematopoietic Proliferations App 20090053233 - De Romeuf; Christophe ;   et al. | 2009-02-26 |
Use of adcc-optimized antibodies for treating weak patients App 20060182741 - Bourel; Dominique ;   et al. | 2006-08-17 |
Treatment of pathologies which escape the immune response, using optimised antibodies App 20050271652 - de Romeuf, Christophe ;   et al. | 2005-12-08 |
Cytokine production-inducing antibody App 20050249732 - de Romeuf, Christophe ;   et al. | 2005-11-10 |